查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1576973

睡眠補助的全球市場的按評估:各產品，睡眠障礙，各地區，機會，預測(2017年～2031年)

Sleep Aids Market Assessment, By Product, By Sleep Disorder, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 246 Pages | 商品交期: 3-5個工作天內

價格

全球睡眠輔助市場規模預計將從 2023 年的 818 億美元增至 2031 年的 1349.7 億美元，在 2024-2031 年的預測期內複合年增長率為 6.46%。由於睡眠障礙患者數量的增加、與睡眠障礙相關的研發活動的增加以及人們對深度睡眠及其健康影響的認識不斷提高，預計該市場將以更快的速度增長。

改善個人睡眠並緩解失眠、睡眠呼吸中止症和不寧腿症候群等睡眠障礙的產品稱為助眠劑。這些選擇包括處方藥、非處方補充劑、草藥以及睡眠追蹤設備和智慧床墊等新技術。近年來，助眠劑的需求急劇增加。這是由於睡眠作為健康和福祉的基本要素的需求不斷增加。壓力增加、忙碌的生活方式以及科技設備的普及也會擾亂睡眠。隨著睡眠不足對健康的負面影響越來越明顯，越來越多的人開始尋求自然療法來解決這個問題。大流行加劇了這些需求，許多人的焦慮程度和睡眠問題加劇。這種情況促使顧客尋求治療，同時也加大了醫療專業人員推薦助眠劑的壓力。隨著越來越多的人患有精神疾病、產品創新不斷增加以及對精神健康問題的容忍度不斷提高，睡眠輔助市場持續增長，引起了消費者和企業的極大興趣。

2023 年 5 月，專注於改造藥物以改善生活的生物製藥公司 Avadel Pharmaceuticals plc 宣布，美國食品藥物管理局 (FDA) 已最終批准 LUMRYZ。 LUMRYZ 是一種羥丁酸鈉緩釋製劑，旨在睡前服用一次，用於治療成人發作性睡病患者的猝倒或日間過度嗜睡 (EDS)。這項最終批准使 LUMRYZ 成為 FDA 批准的第一個也是唯一一個睡前一次用於發作性睡病患者的羥丁酯。此外，LUMRYZ 也獲得 FDA 授予的孤兒藥獨家權利。

本報告研究和分析了全球睡眠輔助市場，提供市場規模和預測、市場動態以及主要參與者的狀況。

目錄

第1章 計劃的範圍和定義

第2章 調查手法

第3章 摘要整理

第4章 全球睡眠補助市場預測(2017年～2031年)

  • 市場規模的分析與預測
    • 金額
  • 市場佔有率的分析與預測
    • 各產品
    • 各睡眠障礙
    • 各地區
    • 市場佔有率分析:各企業(金額)(前五名公司和其他 - 2023年)
  • 市場地圖分析(2023年)
    • 各產品
    • 各睡眠障礙
    • 各終端用戶
    • 各地區

第5章 北美的睡眠補助市場預測(2017年～2031年)

  • 市場規模的分析與預測
    • 金額
  • 市場佔有率的分析與預測
    • 各產品
    • 各睡眠障礙
    • 佔有率:各國
  • 各國的市場評估
    • 美國的睡眠補助市場預測(2017年～2031年)
    • 加拿大
    • 墨西哥

第6章 歐洲的睡眠補助市場預測(2017年～2031年)

  • 德國
  • 法國
  • 義大利
  • 英國
  • 俄羅斯
  • 荷蘭
  • 西班牙
  • 波蘭

第7章 亞太地區的睡眠補助市場預測(2017年～2031年)

  • 印度
  • 中國
  • 日本
  • 澳洲
  • 越南
  • 韓國
  • 印尼
  • 菲律賓

第8章 南美的睡眠補助市場預測(2017年～2031年)

  • 巴西
  • 阿根廷

第9章 中東·非洲的睡眠補助市場預測(2017年～2031年)

  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非
  • 以色列

第10章 供需分析

第11章 進口和出口的分析

第12章 價值鏈分析

第13章 波特的五力分析

第14章 大環境分析

第15章 價格分析

第16章 市場動態

  • 推動市場要素
  • 市場課題

第17章 市場趨勢與發展

第18章 法規結構和革新

  • 臨床試驗
  • 法規當局的認證

第19章 專利形勢

第20章 案例研究

第21章 競爭情形

  • 前五名市場領導者的競爭矩陣
  • 前五名公司的SWOT分析
  • 前十大主要企業的形勢
    • BMC Medical Co., Ltd.
    • Cadwell Industries, Inc.
    • Compumedics Limited
    • Fisher & Paykel Healthcare Limited
    • Merck& Co., Inc.
    • Natus Medical Inc.
    • Koninklijke Philips N.V.
    • Pfizer Inc.
    • Sanofi S.A.
    • SleepMed Inc.

第22章 策略性推薦

第23章 本公司相關資料，免責聲明

Product Code: MX12169

Global sleep aids market is projected to witness a CAGR of 6.46% during the forecast period 2024-2031, growing from USD 81.80 billion in 2023 to USD 134.97 billion in 2031. The market for sleep aids is anticipated to grow at a faster pace under the influence of rising cases of sleep disorders, increased R&D initiatives around sleep disorders, and heightened awareness about sound sleep and its health implications.

Products that help individuals sleep better and mitigate sleep disorders, including insomnia, sleep apnea, and restless leg syndrome, are referred to as sleep aids. This option includes prescription medications, over-the-counter supplements, herbal remedies, and newer technologies such as a sleep-tracking device and smart mattresses. Sleep aids have experienced a highly increasing demand in recent years, heralded by the very awareness of the increasing need for sleep as an integral part of health and wellbeing. Increased stress levels, busy lifestyles, and widespread influences of technological gadgets have also contributed to disturbances in sleep. As the ill effects of sleep deprivation on health become more and more apparent, increasingly more individuals seek natural remedies to eliminate this issue. The pandemic has further fueled these rising needs, with many people experiencing heightened anxiety levels and disturbances in their sleep. These conditions made customers seek a cure, and at the same time, increased pressure on healthcare professionals to recommend sleep aids. As more and more people come forward to discuss mental disorders, product innovation, and increased tolerance toward mental health issues, the sleep aid market continues to gain momentum, thus bringing significant interest to both consumer groups and businesses.

In May 2023, Avadel Pharmaceuticals plc, a biopharmaceutical company focused on transforming medicines to improve lives, announced that the U.S. Food & Drug Administration (FDA) has granted final approval to LUMRYZ. LUMRYZ is an extended-release formulation of sodium oxybate intended to be taken once at bedtime for treating cataplexy or excessive daytime sleepiness (EDS) in adults with narcolepsy. With this final approval, LUMRYZ becomes the first and only FDA-approved once-at-bedtime oxybate for people living with narcolepsy. Additionally, LUMRYZ has been granted Orphan Drug Exclusivity by the FDA.

Rising Sleep Troubles Among People to Boost Market Demand

The growing incidence of sleeping disorders is generating high demand for sleep aids all over the world. There are several reasons for this. The elderly population is more prone to sleeping problems, and the related customer base is huge. Other factors for the increase of sleep disorders including modern lifestyle are stress levels, irregular work hours, and increased time in front of screens, which have disrupted normal sleep cycles in almost all the strata of the population. Public awareness of the need for sleep for overall health leads people to seek effective solutions further and thus increases market demand. Improving technology in sleeping aids, such as wearable devices and smart beds, also upgrades the product offerings and attracts consumers. According to the data of the National Council of Aging, around 39 million adults in the United States suffer from obstructive sleep apnea (OSA) and the number goes up to 936 million adults around the world who have mild to severe OSA. Snoring is a common symptom of sleep apnea in up to 94% of patients.

Growing Focus on R&D for Sleeping Aids to Bring Market Growth

The growth in R&D for sleep aids is expected to propel the market forward. As the issues relating to sleep, such as sleep apnea and insomnia, are increasing, there is a greater demand for a better solution. R&D initiatives have also led to the manufacturing of unique products, natural supplements, and sophisticated sleep technologies, catering to the diverse needs of the consumer. Companies, as well as startup firms, invest heavily in R&D, exploring various new compounds, formulations, as well as delivery methods, that can better improve the quality of sleep without adverse effects. Such products are validated through clinical trials and scientific studies, while consumer confidence generated by those studies boosts adoption. For instance, in July 2024, Corundum Neuroscience awarded a research grant to Tel Aviv University to develop a machine learning-based method for the non-invasive detection of abnormal brain activity in deep brain regions during sleep. The project aims to identify brain activity linked to dementia using high-density EEG. The goal is to create disease-specific biomarkers for neurodegenerative conditions and improve diagnostics and treatment.

Insomnia Segment to Dominate the Market

The insomnia market segment is expected to lead the sleep aid market, as sleeping disorders are on the rise and more people become aware of their health implications. The rising insomnia rates due to stress, anxiety, and lifestyle issues keep more people searching for a healthy solution that would provide them with better quality sleep. Such chronic insomnia affects a large portion of the population, and thus the demand for specialty products, such as prescription medications, over-the-counter supplements, or natural remedies is high. The emergence of new, insomnia-specific formulations and products is also on the rise, enhancing effectiveness and consumer acceptability. Strategic product launches for insomnia treatment further increase its market share, for instance, in July 2024, Jiangsu Simcere Pharmaceutical Co., Ltd. announced that the National Medical Products Administration has accepted the new drug application for Quviviq (daridorexant hydrochloride tablets), an innovative anti-insomnia drug developed in collaboration with Idorsia of Switzerland. Quviviq is a dual orexin receptor antagonist (DORA) and represents a new generation of anti-insomnia drugs. The drug has been approved for marketing in nine countries, including the United States, the United Kingdom, Switzerland, and Canada.

North America Dominates Sleep Aids Market

North America highly dominates the market for sleep aids. Several interrelated factors have placed the region at the top. The first reason is that North America, combined with lifestyle stressors, displays one of the highest rates of sleep disorders, especially insomnia and sleep apnea. Increased screen time and fast-paced work culture have led to this rising prevalence, increasing consumer awareness and demand for effective solutions to sleep issues. Advanced healthcare infrastructure and significant investments in research and development characterize North America as well. The majors, as well as startups, always are innovation and product launch leaders as they develop new sleep aids, prescription as well as over-the-counter formulations for consumers to avail. Culturally, it is pushing further the market with health and wellness awareness that more consumers are eager to find natural and holistic remedies besides pharmaceuticals.

Future Market Scenario (2024-2031F)

Smart mattresses equipped with AI integration are poised to drive significant growth in the sleep aids market. These innovative products utilize advanced sensors to monitor sleep patterns, heart rates, and breathing, providing real-time feedback and personalized sleep recommendations. By adjusting firmness, temperature, and support based on individual needs, smart mattresses enhance overall sleep quality. Furthermore, AI-driven insights can help users understand their sleep behavior, encouraging healthier habits. As consumers increasingly seek personalized and tech-driven solutions to improve sleep, the demand for smart mattresses is expected to rise, positioning them as key players in the evolving sleep aids market. In November 2023, DeRUCCI Group launched the T11 Pro Smart Mattress, the first AIoT smart mattress, designed to enhance sleep quality through advanced technology. It features 23 AI sensors that monitor various health metrics, including body temperature and heart rate, and 18 support airbags that adjust to users' movements. The mattress utilizes a patented algorithm for real-time adjustments tailored to individual sleeping positions, improving spinal health by over 40%. It connects with IoT devices for a fully integrated smart bedroom experience and offers features like snoring intervention and personalized sleep reports.

Key Players Landscape and Outlook

The sleep aid market features a dynamic landscape dominated by key players across pharmaceuticals, supplements, and technology sectors. Prominent pharmaceutical companies, such as Pfizer and Merck, offer prescription medications like Zolpidem and Eszopiclone, focusing on effectiveness and safety to address chronic insomnia. Over-the-counter brands like Unisom and Tylenol cater to consumers seeking immediate relief with accessible solutions. Recent activities in the sleep aids market include regulatory approvals and joint ventures for market expansion.

In March 2024, Vanda Pharmaceuticals Inc. announced that it received a Complete Response Letter (CRL) from the United States Food and Drug Administration (FDA) as part of its ongoing review of Vanda's supplemental New Drug Application (sNDA) for HETLIOZ (tasimelteon) in the treatment of insomnia characterized by difficulties with sleep initiation.

In October 2023, Apnimed, Inc., a clinical-stage pharmaceutical company focused on developing oral pharmacologic therapies for the treatment of obstructive sleep apnea (OSA) and other sleep disorders, announced a new joint venture with Shionogi & Co., Ltd., a leading global research-driven pharmaceutical company based in Japan. The joint venture, called Shionogi-Apnimed Sleep Science, LLC, will initially focus on accelerating the discovery, preclinical, and clinical development of novel pharmacologic solutions designed to address the complex pathology of OSA.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global Sleep Aids Market Outlook, 2017-2031F

  • 4.1. Market Size Analysis & Forecast
    • 4.1.1. By Value
  • 4.2. Market Share Analysis & Forecast
    • 4.2.1. By Product
      • 4.2.1.1. Mattresses and Pillows
      • 4.2.1.2. Sleep Laboratory Services
      • 4.2.1.3. Medication
      • 4.2.1.4. Others
    • 4.2.2. By Sleep Disorder
      • 4.2.2.1. Insomnia
      • 4.2.2.2. Sleep Apnea
      • 4.2.2.3. Restless Legs Syndrome
      • 4.2.2.4. Narcolepsy
      • 4.2.2.5. Sleepwalking
      • 4.2.2.6. Other Sleep Disorders
    • 4.2.3. By Region
      • 4.2.3.1. North America
      • 4.2.3.2. Europe
      • 4.2.3.3. Asia-Pacific
      • 4.2.3.4. South America
      • 4.2.3.5. Middle East and Africa
    • 4.2.4. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2023)
  • 4.3. Market Map Analysis, 2023
    • 4.3.1. By Product
    • 4.3.2. By Sleep Disorder
    • 4.3.3. By End-user
    • 4.3.4. By Region

5. North America Sleep Aids Market Outlook, 2017-2031F*

  • 5.1. Market Size Analysis & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share Analysis & Forecast
    • 5.2.1. By Product
      • 5.2.1.1. Mattresses and Pillows
      • 5.2.1.2. Sleep Laboratory Services
      • 5.2.1.3. Medication
      • 5.2.1.4. Others
    • 5.2.2. By Sleep Disorder
      • 5.2.2.1. Insomnia
      • 5.2.2.2. Sleep Apnea
      • 5.2.2.3. Restless Legs Syndrome
      • 5.2.2.4. Narcolepsy
      • 5.2.2.5. Sleepwalking
      • 5.2.2.6. Other Sleep Disorders
    • 5.2.3. By Country Share
      • 5.2.3.1. United States
      • 5.2.3.2. Canada
      • 5.2.3.3. Mexico
  • 5.3. Country Market Assessment
    • 5.3.1. United States Sleep Aids Market Outlook, 2017-2031F*
      • 5.3.1.1. Market Size Analysis & Forecast
        • 5.3.1.1.1. By Value
      • 5.3.1.2. Market Share Analysis & Forecast
        • 5.3.1.2.1. By Product
          • 5.3.1.2.1.1. Mattresses and Pillows
          • 5.3.1.2.1.2. Sleep Laboratory Services
          • 5.3.1.2.1.3. Medication
          • 5.3.1.2.1.4. Others
        • 5.3.1.2.2. By Sleep Disorder
          • 5.3.1.2.2.1. Insomnia
          • 5.3.1.2.2.2. Sleep Apnea
          • 5.3.1.2.2.3. Restless Legs Syndrome
          • 5.3.1.2.2.4. Narcolepsy
          • 5.3.1.2.2.5. Sleepwalking
          • 5.3.1.2.2.6. Other Sleep Disorders
    • 5.3.2. Canada
    • 5.3.3. Mexico

All segments will be provided for all regions and countries covered

6. Europe Sleep Aids Market Outlook, 2017-2031F

  • 6.1. Germany
  • 6.2. France
  • 6.3. Italy
  • 6.4. United Kingdom
  • 6.5. Russia
  • 6.6. Netherlands
  • 6.7. Spain
  • 6.8. Poland

7. Asia-Pacific Sleep Aids Market Outlook, 2017-2031F

  • 7.1. India
  • 7.2. China
  • 7.3. Japan
  • 7.4. Australia
  • 7.5. Vietnam
  • 7.6. South Korea
  • 7.7. Indonesia
  • 7.8. Philippines

8. South America Sleep Aids Market Outlook, 2017-2031F

  • 8.1. Brazil
  • 8.2. Argentina

9. Middle East and Africa Sleep Aids Market Outlook, 2017-2031F

  • 9.1. Saudi Arabia
  • 9.2. UAE
  • 9.3. South Africa
  • 9.4. Israel

10. Demand Supply Analysis

11. Import and Export Analysis

12. Value Chain Analysis

13. Porter's Five Forces Analysis

14. PESTLE Analysis

15. Pricing Analysis

16. Market Dynamics

  • 16.1. Market Drivers
  • 16.2. Market Challenges

17. Market Trends and Developments

18. Regulatory Framework and Innovation

  • 18.1. Clinical Trials
  • 18.2. Regulatory Approvals

19. Patent Landscape

20. Case Studies

21. Competitive Landscape

  • 21.1. Competition Matrix of Top 5 Market Leaders
  • 21.2. SWOT Analysis for Top 5 Players
  • 21.3. Key Players Landscape for Top 10 Market Players
    • 21.3.1. BMC Medical Co., Ltd.
      • 21.3.1.1. Company Details
      • 21.3.1.2. Key Management Personnel
      • 21.3.1.3. Products and Services
      • 21.3.1.4. Financials (As Reported)
      • 21.3.1.5. Key Market Focus and Geographical Presence
      • 21.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
    • 21.3.2. Cadwell Industries, Inc.
    • 21.3.3. Compumedics Limited
    • 21.3.4. Fisher & Paykel Healthcare Limited
    • 21.3.5. Merck& Co., Inc.
    • 21.3.6. Natus Medical Inc.
    • 21.3.7. Koninklijke Philips N.V.
    • 21.3.8. Pfizer Inc.
    • 21.3.9. Sanofi S.A.
    • 21.3.10. SleepMed Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

22. Strategic Recommendations

23. About Us and Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Sleep Aids Market, By Value, In USD Billion, 2017-2031F
  • Figure 2. Global Sleep Aids Market Share (%), By Product, 2017-2031F
  • Figure 3. Global Sleep Aids Market Share (%), By Sleep Disorder, 2017-2031F
  • Figure 4. Global Sleep Aids Market Share (%), By Region, 2017-2031F
  • Figure 5. North America Sleep Aids Market, By Value, In USD Billion, 2017-2031F
  • Figure 6. North America Sleep Aids Market Share (%), By Product, 2017-2031F
  • Figure 7. North America Sleep Aids Market Share (%), By Sleep Disorder, 2017-2031F
  • Figure 8. North America Sleep Aids Market Share (%), By Country, 2017-2031F
  • Figure 9. United States Sleep Aids Market, By Value, In USD Billion, 2017-2031F
  • Figure 10. United States Sleep Aids Market Share (%), By Product, 2017-2031F
  • Figure 11. United States Sleep Aids Market Share (%), By Sleep Disorder, 2017-2031F
  • Figure 12. Canada Sleep Aids Market, By Value, In USD Billion, 2017-2031F
  • Figure 13. Canada Sleep Aids Market Share (%), By Product, 2017-2031F
  • Figure 14. Canada Sleep Aids Market Share (%), By Sleep Disorder, 2017-2031F
  • Figure 15. Mexico Sleep Aids Market, By Value, In USD Billion, 2017-2031F
  • Figure 16. Mexico Sleep Aids Market Share (%), By Product, 2017-2031F
  • Figure 17. Mexico Sleep Aids Market Share (%), By Sleep Disorder, 2017-2031F
  • Figure 18. Europe Sleep Aids Market, By Value, In USD Billion, 2017-2031F
  • Figure 19. Europe Sleep Aids Market Share (%), By Product, 2017-2031F
  • Figure 20. Europe Sleep Aids Market Share (%), By Sleep Disorder, 2017-2031F
  • Figure 21. Europe Sleep Aids Market Share (%), By Country, 2017-2031F
  • Figure 22. Germany Sleep Aids Market, By Value, In USD Billion, 2017-2031F
  • Figure 23. Germany Sleep Aids Market Share (%), By Product, 2017-2031F
  • Figure 24. Germany Sleep Aids Market Share (%), By Sleep Disorder, 2017-2031F
  • Figure 25. France Sleep Aids Market, By Value, In USD Billion, 2017-2031F
  • Figure 26. France Sleep Aids Market Share (%), By Product, 2017-2031F
  • Figure 27. France Sleep Aids Market Share (%), By Sleep Disorder, 2017-2031F
  • Figure 28. Italy Sleep Aids Market, By Value, In USD Billion, 2017-2031F
  • Figure 29. Italy Sleep Aids Market Share (%), By Product, 2017-2031F
  • Figure 30. Italy Sleep Aids Market Share (%), By Sleep Disorder, 2017-2031F
  • Figure 31. United Kingdom Sleep Aids Market, By Value, In USD Billion, 2017-2031F
  • Figure 32. United Kingdom Sleep Aids Market Share (%), By Product, 2017-2031F
  • Figure 33. United Kingdom Sleep Aids Market Share (%), By Sleep Disorder, 2017-2031F
  • Figure 34. Russia Sleep Aids Market, By Value, In USD Billion, 2017-2031F
  • Figure 35. Russia Sleep Aids Market Share (%), By Product, 2017-2031F
  • Figure 36. Russia Sleep Aids Market Share (%), By Sleep Disorder, 2017-2031F
  • Figure 37. Netherlands Sleep Aids Market, By Value, In USD Billion, 2017-2031F
  • Figure 38. Netherlands Sleep Aids Market Share (%), By Product, 2017-2031F
  • Figure 39. Netherlands Sleep Aids Market Share (%), By Sleep Disorder, 2017-2031F
  • Figure 40. Spain Sleep Aids Market, By Value, In USD Billion, 2017-2031F
  • Figure 41. Spain Sleep Aids Market Share (%), By Product, 2017-2031F
  • Figure 42. Spain Sleep Aids Market Share (%), By Sleep Disorder, 2017-2031F
  • Figure 43. Turkey Sleep Aids Market, By Value, In USD Billion, 2017-2031F
  • Figure 44. Turkey Sleep Aids Market Share (%), By Product, 2017-2031F
  • Figure 45. Turkey Sleep Aids Market Share (%), By Sleep Disorder, 2017-2031F
  • Figure 46. Poland Sleep Aids Market, By Value, In USD Billion, 2017-2031F
  • Figure 47. Poland Sleep Aids Market Share (%), By Product, 2017-2031F
  • Figure 48. Poland Sleep Aids Market Share (%), By Sleep Disorder, 2017-2031F
  • Figure 49. South America Sleep Aids Market, By Value, In USD Billion, 2017-2031F
  • Figure 50. South America Sleep Aids Market Share (%), By Product, 2017-2031F
  • Figure 51. South America Sleep Aids Market Share (%), By Sleep Disorder, 2017-2031F
  • Figure 52. South America Sleep Aids Market Share (%), By Country, 2017-2031F
  • Figure 53. Brazil Sleep Aids Market, By Value, In USD Billion, 2017-2031F
  • Figure 54. Brazil Sleep Aids Market Share (%), By Product, 2017-2031F
  • Figure 55. Brazil Sleep Aids Market Share (%), By Sleep Disorder, 2017-2031F
  • Figure 56. Argentina Sleep Aids Market, By Value, In USD Billion, 2017-2031F
  • Figure 57. Argentina Sleep Aids Market Share (%), By Product, 2017-2031F
  • Figure 58. Argentina Sleep Aids Market Share (%), By Sleep Disorder, 2017-2031F
  • Figure 59. Asia-Pacific Sleep Aids Market, By Value, In USD Billion, 2017-2031F
  • Figure 60. Asia-Pacific Sleep Aids Market Share (%), By Product, 2017-2031F
  • Figure 61. Asia-Pacific Sleep Aids Market Share (%), By Sleep Disorder, 2017-2031F
  • Figure 62. Asia-Pacific Sleep Aids Market Share (%), By Country, 2017-2031F
  • Figure 63. India Sleep Aids Market, By Value, In USD Billion, 2017-2031F
  • Figure 64. India Sleep Aids Market Share (%), By Product, 2017-2031F
  • Figure 65. India Sleep Aids Market Share (%), By Sleep Disorder, 2017-2031F
  • Figure 66. China Sleep Aids Market, By Value, In USD Billion, 2017-2031F
  • Figure 67. China Sleep Aids Market Share (%), By Product, 2017-2031F
  • Figure 68. China Sleep Aids Market Share (%), By Sleep Disorder, 2017-2031F
  • Figure 69. Japan Sleep Aids Market, By Value, In USD Billion, 2017-2031F
  • Figure 70. Japan Sleep Aids Market Share (%), By Product, 2017-2031F
  • Figure 71. Japan Sleep Aids Market Share (%), By Sleep Disorder, 2017-2031F
  • Figure 72. Australia Sleep Aids Market, By Value, In USD Billion, 2017-2031F
  • Figure 73. Australia Sleep Aids Market Share (%), By Product, 2017-2031F
  • Figure 74. Australia Sleep Aids Market Share (%), By Sleep Disorder, 2017-2031F
  • Figure 75. Vietnam Sleep Aids Market, By Value, In USD Billion, 2017-2031F
  • Figure 76. Vietnam Sleep Aids Market Share (%), By Product, 2017-2031F
  • Figure 77. Vietnam Sleep Aids Market Share (%), By Sleep Disorder, 2017-2031F
  • Figure 78. South Korea Sleep Aids Market, By Value, In USD Billion, 2017-2031F
  • Figure 79. South Korea Sleep Aids Market Share (%), By Product, 2017-2031F
  • Figure 80. South Korea Sleep Aids Market Share (%), By Sleep Disorder, 2017-2031F
  • Figure 81. Indonesia Sleep Aids Market, By Value, In USD Billion, 2017-2031F
  • Figure 82. Indonesia Sleep Aids Market Share (%), By Product, 2017-2031F
  • Figure 83. Indonesia Sleep Aids Market Share (%), By Sleep Disorder, 2017-2031F
  • Figure 84. Philippines Sleep Aids Market, By Value, In USD Billion, 2017-2031F
  • Figure 85. Philippines Sleep Aids Market Share (%), By Product, 2017-2031F
  • Figure 86. Philippines Sleep Aids Market Share (%), By Sleep Disorder, 2017-2031F
  • Figure 87. Middle East & Africa Sleep Aids Market, By Value, In USD Billion, 2017-2031F
  • Figure 88. Middle East & Africa Sleep Aids Market Share (%), By Product, 2017-2031F
  • Figure 89. Middle East & Africa Sleep Aids Market Share (%), By Sleep Disorder, 2017-2031F
  • Figure 90. Middle East & Africa Sleep Aids Market Share (%), By Country, 2017-2031F
  • Figure 91. Saudi Arabia Sleep Aids Market, By Value, In USD Billion, 2017-2031F
  • Figure 92. Saudi Arabia Sleep Aids Market Share (%), By Product, 2017-2031F
  • Figure 93. Saudi Arabia Sleep Aids Market Share (%), By Sleep Disorder, 2017-2031F
  • Figure 94. UAE Sleep Aids Market, By Value, In USD Billion, 2017-2031F
  • Figure 95. UAE Sleep Aids Market Share (%), By Product, 2017-2031F
  • Figure 96. UAE Sleep Aids Market Share (%), By Sleep Disorder, 2017-2031F
  • Figure 97. South Africa Sleep Aids Market, By Value, In USD Billion, 2017-2031F
  • Figure 98. South Africa Sleep Aids Market Share (%), By Product, 2017-2031F
  • Figure 99. South Africa Sleep Aids Market Share (%), By Sleep Disorder, 2017-2031F
  • Figure 100. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 101. By Sleep Disorder Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 102. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023